|
HS Code |
721091 |
| Productname | 4-Bromo-2-Methylisoindolin-1-One |
| Molecularformula | C9H8BrNO |
| Molecularweight | 226.07 g/mol |
| Casnumber | 898771-66-3 |
| Appearance | White to off-white solid |
| Meltingpoint | 148-152°C |
| Purity | Typically ≥ 98% |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Smiles | CC1C2=CC(=C(C=C2)Br)C(=O)N1 |
| Inchi | InChI=1S/C9H8BrNO/c1-5-6-3-2-7(10)4-8(6)9(12)11-5/h2-5H,1H3,(H,11,12) |
| Storagetemperature | Store at 2-8°C |
| Hscode | 29339980 |
As an accredited 4-Bromo-2-Methylisoindolin-1-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Methylisoindolin-1-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the evolving landscape of chemical synthesis, one compound quietly stands out: 4-Bromo-2-Methylisoindolin-1-One. Its name rolls off the tongue more like a coded message than a familiar ingredient, yet for anyone who works in a lab or supports pharmaceutical R&D, this compound offers more certainty than its cryptic title suggests. I’ve seen plenty of molecules that promise value to synthetic chemists, but few offer a mix of structure and reactivity that matches what’s found here.
Researchers, engineers, and producers need reliable intermediates—ones that don’t throw surprises halfway through a reaction or overstretch a project’s safety or cost profile. 4-Bromo-2-Methylisoindolin-1-One fills an important spot here, helping to build complex molecules with a degree of predictability I’ve come to count on. The compound isn’t flashy; you won’t see it featured in glossy brochures or trend pieces. Instead, its worth shows up where it counts: in clean reactions, reproducible yields, and manageable steps for both small batches and scale-up runs.
The structure of 4-Bromo-2-Methylisoindolin-1-One, with its bromine at position 4 and methyl group at position 2, forms a backbone ready to handle demand from research or production routes. Chemically, that bromo group makes it a strong candidate for further transformations—those Suzuki and Heck couplings come to mind, where cross-coupling creates opportunity to build elaborate targets with less hassle. For many, this makes the compound a go-to intermediate and not just a sideline option.
Typical batches come as off-white to pale yellow crystalline solids, with a molar mass suited for efficient weighing and transfer in glass or plastic. I’ve never had much trouble with its physical handling—it flows well, cleans up cleanly, and resists the sort of moisture pick-up that causes headaches with some other fine chemicals. Critical for anyone sourcing key starting materials, 4-Bromo-2-Methylisoindolin-1-One consistently delivers high purity with robust HPLC and NMR profiles, which means fewer re-tests, confident batch traceability, and less uncertainty hanging over your project timeline.
What sets this particular isoindolinone apart? In my experience, the core structure taps into the sweet spot between stability and reactivity. Chemists love stability for storage and handling, but they need reactivity in the vessel when it’s time to move the process forward. The presence of the bromine atom dramatically changes this molecule’s response to catalysts and nucleophiles—essentially handing synthetic chemists the tools to attach, rearrange, or elongate chemical frameworks for targets as diverse as oncology leads, agricultural actives, and performance materials. It stands out from close cousins in the isoindolin-1-one family, whose substituents don’t always allow for such smooth transformation under mild conditions.
On the practical side, I’ve watched teams switch to this intermediate from less reactive, less compatible options and immediately see a reduction in problem reactions. The yields go up, purification steps drop off, and troublesome byproducts tend to shrink away. For those who have wrestled with costly purification or inconsistent byproduct profiles, these kinds of gains can make or break a research effort’s success.
Anyone working on active pharmaceutical ingredients or specialty polymers has bumped into the endless lineup of available aromatic intermediates. Many feature a halogen or alkyl group in key positions. What I’ve consistently found with 4-Bromo-2-Methylisoindolin-1-One lies in its unique pairing of the bromine atom, which acts as a versatile leaving group, and the methyl group, which affects reactivity and solubility just enough to set it apart. Some folks reach for 4-chloro or 4-iodo analogs, but the bromine variant frequently lands in the “just right” category—strong enough to drive transformation, but not so unwieldy that cost or stability falls apart.
Methyl substituents on the ring influence not only electronic characteristics but also physical properties. This difference has played out on the bench and in pilot runs, with 4-bromo versions outperforming chloro or fluoro cousins in clean reaction control and solubility. Having run comparative reactions side by side, I know the subtle changes can tip the balance: some analogs gum up stirrers or dissolve less easily, eating up time and supplies. While other compounds may offer similar skeletons, few match both this combination of group placement and ease of modification in subsequent steps.
Field application usually begins in the early exploratory stage where choosing the right precursor can shape the outcome of downstream steps. In medicinal chemistry, introducing modifications at the 4-position starts to tune pharmacokinetic properties, binding affinities, or metabolic stability, crucial for projects aiming to improve bioavailability or target selectivity. 4-Bromo-2-Methylisoindolin-1-One has landed in hit-to-lead and lead optimization pipelines for these reasons, providing reliable scaffolding for medicinal chemists to work with.
Basic researchers exploring new synthetic methodologies also lean on this intermediate—I’ve found its stability makes it easier to test new catalysts or ligands without unexpected decomposition spoiling the day’s work. For those building libraries quickly, this intermediate’s ready availability in high purity means screening can move at a clip, freeing up time and resources for what really matters: following up on real biological or material activity.
Process development teams have shared similar stories: reactions using this compound usually require milder conditions, so vessel wear, solvent recovery, and energy input all drop—each critical for cost containment at larger scale. Plus, the reduced number of byproducts slashes the effort needed for downstream separation and waste treatment. This matters immensely when every marginal gain, every shorter batch time feeds into providing new drugs or advanced materials at a price people can actually pay.
As a chemist who’s watched molecules move from benchtop to kilo scale and beyond, I know that not every intermediate deserves the label of “workhorse.” Some offer little more than basic building blocks, leaving everything else—selectivity, efficiency, cost—to luck or post-synthesis pain points. 4-Bromo-2-Methylisoindolin-1-One supports projects at almost every stage, from exploratory routes to full-scale manufacturing campaigns. It’s not just about reliability; it’s about enabling research and manufacturing teams to put their focus where it counts, rather than getting sidetracked by the shortfalls of a poor intermediate.
Choosing this product means avoiding the sort of pitfalls that eat up budgets: difficult purifications, inconsistent performance, or stubborn reactivity. Over my years on the bench and in process scale-up, I’ve seen the difference these details can make. A stumbling block early on can domino into weeks of troubleshooting, whereas a choice intermediate keeps momentum on track and opens the door for process improvements that actually stick beyond the development phase.
Nothing in the world of organic synthesis is immune to the laws of scale or the quirks of process adaptation. While 4-Bromo-2-Methylisoindolin-1-One brings a slew of benefits, it’s wise to consider the usual suspects: impurity management, proper containment to prevent environmental release, and rigorous quality control—especially for teams working in regulated pharma or fine chemical facilities. Its reactivity, while generally a plus, deserves respect; residues and waste streams call for responsible handling to avoid cross-contamination.
Teams that take a comprehensive approach—pairing solid supplier qualification with on-site analytical confidence—tend to get the most from this intermediate. Timely testing, traceable batch records, and open communication between supplier and end-user ensure that hiccups get caught early, before small variances snowball into major headaches. If your operation prizes process consistency and quality, committing to these practices means you’ll see every advantage this product has to offer.
I’ve always been a stickler for safe lab practice, not just because of regulations, but because keeping people and the planet safe simply makes sense for long-term viability. 4-Bromo-2-Methylisoindolin-1-One’s solid nature and moderate volatility makes it less bothersome to weigh and transfer than some liquid or dust-prone alternatives, but gloves and fume hood usage remain musts. Waste management shouldn’t fall by the wayside, either; brominated byproducts call for solid planning around disposal and recycling if available.
Beyond safety, the ripple effects matter, especially with the increasing focus on green chemistry and sustainability. While 4-Bromo-2-Methylisoindolin-1-One enables milder, more selective reactions, there’s always room for smarter solvent choice, more efficient purification, and closed-loop recycling. As process chemists, our challenge stays the same: keep yields high and costs low without cutting corners that catch up with us down the road.
Supply chain stability continues to ride high on everyone’s list these days. Access to high-purity intermediates, especially ones with pharmaceutical or advanced materials pedigree, has never been more critical. While demand increases worldwide, finding partners who can supply reliable, consistent lots—without surprise price spikes or gaps in quality—keeps research and production lines running smoothly.
In recent years, I’ve seen procurement teams gravitate towards intermediates like 4-Bromo-2-Methylisoindolin-1-One precisely because they offer more predictable sourcing and less headache during customs or regulatory review. Its established synthesis and transport protocols help minimize delays, and most suppliers keep strong documentation to ease global compliance. In a field where timely delivery and quality paperwork spell the difference between smooth project launches and costly slowdowns, every bit of predictability helps.
Talk to most researchers who rely on building block intermediates, and you’ll hear a familiar refrain: the need for speed, control, and confidence. There’s little patience for finicky chemicals that break down in transit or tie up valuable time on repeated purifications. I remember watching younger colleagues light up after their first successful coupling using 4-Bromo-2-Methylisoindolin-1-One—they appreciated how little tuning was needed to drive the transformation forward. Cleaning up after the run, they found fewer byproducts and easier phase splits, which translated to more time spent pursuing creative targets, fewer hours tied up in the weeds.
Those early wins add up, especially in fast-paced teams desperate to move promising molecules to the next milestone. By giving researchers a proven tool, this intermediate supports not just the chemistry, but the morale and momentum that define thriving labs.
Switching to a more dependable intermediate may sound like a small shift. In practice, it radically changes the game. Consistency becomes a powerful advantage in the lab and plant. With 4-Bromo-2-Methylisoindolin-1-One, I’ve noticed scale-up trials that once needed workaround after workaround now flow more smoothly. Teams report fewer out-of-spec batches and — just as importantly — less uncertainty from analytical checks. The less time spent second-guessing your input, the more resources can be thrown at innovation, optimization, or delivery timelines.
Every industry suffers from unpredictable factors—weather, regulatory changes, and supply chain upsets—so locking down dependable touchpoints in the workflow helps manage everything else better. This intermediate may not sing and dance, but reliability is its own kind of quiet strength in this world.
There’s no such thing as a perfect product or process, and chemistry marches on. I’d like to see even more transparency in global supply: open data on synthesis methods, impurity profiles, and ecological footprints. If the next wave of advances in greener bromination or closed-loop production hits the market, 4-Bromo-2-Methylisoindolin-1-One will continue to offer competitive advantages—both for pragmatic process benefits and for meeting stakeholder expectations around sustainability.
Exploring new catalysts, solvents, and purification techniques could bring costs down even further, especially for teams running on tight budgets. Open exchange of best practices and smarter sharing of analytical insights, across borders and sectors, will help both buyers and makers improve reliability and reduce surprises.
Modern manufacturing and research calls for more than just molecules—it demands products that work harder, with fewer complications or corners cut. 4-Bromo-2-Methylisoindolin-1-One doesn’t ask for special handling beyond industry standards, so teams can focus on fine-tuning the rest of the process. Reliable supply, consistent purity, and straightforward integration with common synthetic methods provide the foundation. What grows from there—whether an important pharmaceutical, a novel material, or a scalable green process—depends on the creativity and skill of the people wielding these building blocks.
For groups looking to innovate or simply smooth out bumpy workflows, this intermediate is a low-risk, high-reward addition. It might not make the front page, but in the rhythm of real-world research, sometimes it’s the unsung heroes that get the work done.
The future of chemistry, in my eyes, comes down to connection: linking researchers, suppliers, regulators, and end-users in a chain built on trust and openness. With compounds like 4-Bromo-2-Methylisoindolin-1-One, the stage is set for smoother collaboration, fewer breakdowns along the line, and more reliable data at every link in the supply and production chain. Responsible stewardship—careful record-keeping, data-driven evaluations, and honest supplier-customer dialogue—will keep this product not just relevant, but instrumental, as the stakes in R&D and manufacturing rise ever higher.
Instead of isolated islands of innovation, broad adoption and shared expertise can push standards higher, cut waste further, and improve the economics of discovery. Getting better outcomes from our intermediates isn’t a pipe dream; it’s a matter of putting proven products like this one at the center of open, ongoing improvement.
For every advanced material or new healthcare breakthrough, a long chain of building blocks works quietly in the background. 4-Bromo-2-Methylisoindolin-1-One stands as one of those essential enablers—a product grounded in practical chemistry and born from sustained demand for compounds that do their job with little drama. Its reputation grows not from splashy marketing, but from the hands-on success of scientists and engineers who see time and again how a single better choice, upstream, cascades into better results all the way down the pipeline.
Not every compound can carry such steady responsibility. Years of trial and error, incremental learning, and teamwork shape every batch that leaves a supplier’s door. And it’s these daily efforts, nourished by feedback and continuous improvement, that give even a quietly reliable intermediate like this one a seat at the table as research and production tackle bigger, tougher goals.
I’ve handled countless intermediates and specialty chemicals, both as a researcher and a troubleshooter in scaled-up production runs. Some products demand constant vigilance, with quirks that chew through time and resources. Others, like 4-Bromo-2-Methylisoindolin-1-One, let you work with more confidence and less second-guessing. Progress in chemistry isn’t always about finding the brightest, most novel compound; often, it’s about finding a foundation you can trust, project after project.
For students, staff scientists, or process engineers feeling the pressure of deadlines and budgets, a reliable intermediate gives back hours and mental energy you can’t put a price on. Picking a product tested and trusted by your peers replaces unknowns with experience and lets you spend more time pursuing solutions—and less time solving avoidable problems.
In the end, that’s the real mark of 4-Bromo-2-Methylisoindolin-1-One: not just as another tick in a catalog, but as a practical partner in the relentless push for better, faster, safer outcomes in chemistry and beyond.